Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Biological Regulators and Homeostatic Agents

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 22217990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells

  2010cited by this paper
• Adjuvant colon cancer chemotherapy: where we are and where we'll go.

  2010cited by this paper
• Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems

  2009cited by this paper
• Antiproliferative effects of selenium compounds in colon cancer cells: comparison of different cytotoxicity assays.

  2009cited by this paper
• In vitro assays for the evaluation of drug resistance in tumor cells

  2009cited by this paper
• The Challenge of Culturing Human Colorectal Tumor Cells: Establishment of a Cell Culture Model by the Comparison of Different Methodological Approaches

  2009cited by this paper
• Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

  2007cited by this paper
• In vitro treatment of monocytes with 8‐methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype

  2007cited by this paper
• Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo

  2007cited by this paper
• Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines.

  2007cited by this paper
• Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.

  2007cited by this paper
• Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features.

  2007cited by this paper
• Suppression of primary breast, colon, gastric and bladder cancers cell growth in vitro by CKBM, a natural product

  2006cited by this paper
• A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer.

  2005cited by this paper
• In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines

  2005cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells

  2004cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003cited by this paper
• Correlation between metastatic potential and variants from colorectal tumor cell line HT-29.

  2003cited by this paper
• Follow-up of patients with colorectal cancer: numbers needed to test and treat.

  2002cited by this paper
• Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.

  2001cited by this paper
• Oxaliplatin-induced damage of cellular DNA.

  2000cited by this paper
• Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.

  1996cited by this paper
• Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.

  1995cited by this paper
• Features of apoptotic cells measured by flow cytometry.

  1992cited by this paper
• Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexes.

  1989cited by this paper
• Classification of human colorectal adenocarcinoma cell lines.

  1976cited by this paper

• A computational assessment of the interaction of 5Fluorouracil (5FU) drug connected to B_12P_12 and ScB_11P_12 nanocages with adenine nucleobase: DFT, AIM, TD-DFT study

  2023cites this paper
• FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures

  2022cites this paper
• Post-Marketing Surveillance of a generic Oxaliplatin (AlvoxalⓇ) in Iranian Patients with Cancer

  2021cites this paper
• Theoretical investigation of the adsorption behaviors of fluorouracil as an anticancer drug on pristine and B-, Al-, Ga-doped C36 nanotube

  2020cites this paper
• Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.

  2019cites this paper
• Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells

  2018cites this paper
• Rationale for the administration of systemic 5-FU in combination with heated intraperitonal oxaliplatin.

  2018cites this paper
• FU Synergistically Inhibits MCF-7 in Combination with Methylglyoxal

  2017cites this paper
• A comparative study of 5-Fluorouracil release from chitosan/silver and chitosan/silver/MWCNT nanocomposites and their cytotoxicity towards MCF-7.

  2016cites this paper
• A comparative study of 5-Fluorouracil release from chitosan/silver and chitosan/silver/MWCNT nanocomposites and their cytotoxicity towards MCF-7.

  2016cites this paper
• Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin.

  2016cites this paper
• Antiproliferative effects of 5-fluorouracil and oxaliplatin in colon cancer cell lines: comparison of three different cytotoxicity assays.

  2013cites this paper
• Impact of IL-33 on PGD2 Generation by Activated Human Cord Blood-Derived Mast Cell: Lack of Effect on Tryptase Release

  2012cites this paper
• Endothelial Cells, Cholesterol, Cytokines, and Aging

  2012cites this paper
• Nutrition and Cancer Prevention

  2012cites this paper